Influence of Nutrition in Depression Treatment (INDEPT)
NCT05745194 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190
Last updated 2024-08-06
Summary
The hypothesis to be tested by this study is that an intervention promoting adherence to the MedDiet can decrease symptoms of depression in patients with elevated inflammation biomarkers, namely C-reactive protein (CRP) and Interleukin 6 (IL-6) diagnosed with Major Depression Disorder (MDD), under treatment with antidepressant medication for a period of time less than or equal to 6 months.
The main aim of this study is to understand if promoting the adherence to the MedDiet, as an adjuvant strategy in the treatment of MDD, is effective in decreasing symptoms of depression in MDD patients, with elevated levels of inflammation biomarkers.
Other specific objectives of the study are
1. To assess the association between adherence to MedDiet and changes in inflammatory biomarkers;
2. To assess the association between changes in inflammatory biomarkers with symptoms of MDD;
3. To evaluate the association between adherence to MedDiet and effectiveness of psychiatric treatment of MDD;
4. To characterize the association between adherence to MedDiet and changes in health-related quality of life
5. To evaluate the economic cost-effectiveness of dietary counselling, as an adjuvant treatment in MDD.
The study will have a duration of 12 weeks, with a randomized parallel-group open controlled trial design, with two parallel groups with an allocation ratio of 1:1 - (a) intervention arm with six nutritional consultations with a registered nutritionist, promoting adherence to MedDiet, in addition to MDD Treatment-As-Usual (TAU) and (b) control group arm benefitting only from MDD TAU. A follow up assessment will be performed at 6- and 12-months.
Having into consideration an attrition of 40 percentage at the end of the intervention, the minimum sample size estimated is 190 (95 per arm).
The main outcome of the trial, changes in symptoms of depression, will be evaluated using the Beck Depression Inventory Second Edition (BDI-II).
Conditions
- Major Depressive Disorder - MDD
Interventions
- BEHAVIORAL
-
Promotion of adherence to the MedDiet
Participants will be followed in six individual nutrition consultations with a duration of 30 to 60 minutes. The consultations will be focused on promoting the adherence to the MedDiet. The nutritional intervention will be personalized to each individual ad libitum, without calories or macronutrients restriction and without the goal to promote weight change. The intervention will begin with an initial assessment of the dietary patterns of the participants in which the nutritionist will identify potential behavioural changes to promote adjustments in dietary habits and therefore adherence to the MedDiet. The intervention will promote positive recommendations (behaviours recommended to follow) and negative recommendations (behaviours recommended to reduce or eliminate) (26), using the strategy and MedDiet definition proposed by Estruch et al. in the "Primary Prevention of Cardiovascular Disease with a Mediterranean Diet" study (3). The participants will also maintain MDD TAU.
Sponsors & Collaborators
-
University of Lisbon
collaborator OTHER -
Instituto Politécnico de Leiria
collaborator OTHER -
Fundação para a Ciência e a Tecnologia
collaborator OTHER -
Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA
lead OTHER
Principal Investigators
-
Maria João Heitor, PhD · Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, Portugal
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-05
- Primary Completion
- 2025-01-31
- Completion
- 2025-12-31
Countries
- Portugal
Study Locations
More Related Trials
-
Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
NCT07009223 ·Status: RECRUITING ·Phase: NA
-
Physical Activity-based Intervention in Depressed Patients: Clinical, Neurophysiological, Epigenetic and Metabolic Correlates
NCT06989944 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy?
NCT02938559 ·Status: COMPLETED ·Phase: NA
-
Assesment of Vitamin B6 Level in Patients With Major Depressive Disorder
NCT05649293 ·Status: NOT_YET_RECRUITING
-
Association of Peripheral Immune Cells With Antidepressant Treatment Response
NCT06182722 ·Status: RECRUITING
-
Wellness Monitoring for Major Depressive Disorder
NCT02934334 ·Status: COMPLETED
-
Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder
NCT01699490 ·Status: UNKNOWN ·Phase: PHASE4
-
Internet-Based Interventions for MDD
NCT04684277 ·Status: UNKNOWN ·Phase: NA
-
Mediterranean-style Dietary Pattern (MDP), Mood and Anxiety
NCT05927376 ·Status: COMPLETED ·Phase: NA
-
MIND Diet in Relation to Malnutrition and Depression in AD
NCT07163923 ·Status: COMPLETED
-
Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder
NCT01682785 ·Status: UNKNOWN
-
Predictive Nature of Total Cholesterol Threshold: Possible Link to Suicidal Behavior
NCT02847741 ·Status: UNKNOWN ·Phase: NA
-
Improving Depression Outcome by Enhancing Memory for Cognitive Therapy
NCT01790919 ·Status: COMPLETED ·Phase: PHASE2
-
Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale
NCT03872492 ·Status: TERMINATED ·Phase: NA
-
Feasibility and Acceptability of a Healthy Nordic Diet Intervention in Depressed and Non-depressed Adults
NCT04731454 ·Status: COMPLETED ·Phase: NA
-
Effect of Short-Term Mindfulness-Based Training For Major Depression Disorder: An Eye-Tracking Study
NCT04071886 ·Status: UNKNOWN ·Phase: NA
-
Objective Diagnostic Markers and Personalized Intervention in MDD Patients
NCT02023567 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)
NCT03014544 ·Status: COMPLETED
-
Predictive Effect of Neuroinflammatory Factors of the MECT in Treatment of Senile Depression
NCT05597566 ·Status: UNKNOWN
-
Cerebral Neuroinflammation During Major Depressive Episode
NCT03314155 ·Status: UNKNOWN ·Phase: NA
-
Effect of Physical Activity on Depressive Symptoms With a 5 Month Follow-up
NCT01995422 ·Status: COMPLETED ·Phase: NA
-
Neurobiological Effects of Light on MDD
NCT02940769 ·Status: TERMINATED ·Phase: NA
-
Peripheral Immunomarker Validation in Treatment-resistant Depression
NCT02752178 ·Status: COMPLETED
-
Functional and Metabolic Changes in the Course of Antidepressive Treatment
NCT02099630 ·Status: COMPLETED
-
Major Depressive Disorder (MDD)
NCT01662817 ·Status: COMPLETED